66 related articles for article (PubMed ID: 11726199)
21. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
[TBL] [Abstract][Full Text] [Related]
22. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
24. LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes.
Kang YM; Kim SY; Kang JH; Han SW; Nam EJ; Kyung HS; Park JY; Kim IS
Arthritis Rheum; 2007 Apr; 56(4):1106-17. PubMed ID: 17393389
[TBL] [Abstract][Full Text] [Related]
25. TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells.
Kimura M; Haisa M; Uetsuka H; Takaoka M; Ohkawa T; Kawashima R; Yamatsuji T; Gunduz M; Kaneda Y; Tanaka N; Naomoto Y
Cell Death Differ; 2003 Jun; 10(6):718-28. PubMed ID: 12761580
[TBL] [Abstract][Full Text] [Related]
26. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
[TBL] [Abstract][Full Text] [Related]
28. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4).
Pappas IS; Sophianos D; Tzartos S; Tsiftsoglou AS
Cell Growth Differ; 1996 Jun; 7(6):797-809. PubMed ID: 8780893
[TBL] [Abstract][Full Text] [Related]
29. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.
Madge LA; Kluger MS; Orange JS; May MJ
J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573
[TBL] [Abstract][Full Text] [Related]
30. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.
Zhai Y; Guo R; Hsu TL; Yu GL; Ni J; Kwon BS; Jiang GW; Lu J; Tan J; Ugustus M; Carter K; Rojas L; Zhu F; Lincoln C; Endress G; Xing L; Wang S; Oh KO; Gentz R; Ruben S; Lippman ME; Hsieh SL; Yang D
J Clin Invest; 1998 Sep; 102(6):1142-51. PubMed ID: 9739048
[TBL] [Abstract][Full Text] [Related]
31. Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.
Bechill J; Muller WJ
Mol Immunol; 2014 Nov; 62(1):96-103. PubMed ID: 24980868
[TBL] [Abstract][Full Text] [Related]
32. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth.
Harrop JA; McDonnell PC; Brigham-Burke M; Lyn SD; Minton J; Tan KB; Dede K; Spampanato J; Silverman C; Hensley P; DiPrinzio R; Emery JG; Deen K; Eichman C; Chabot-Fletcher M; Truneh A; Young PR
J Biol Chem; 1998 Oct; 273(42):27548-56. PubMed ID: 9765287
[TBL] [Abstract][Full Text] [Related]
33. Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide.
Prados J; Melguizo C; Fernandez JE; Aranega AE; Alvarez L; Aranega A
Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):525-36. PubMed ID: 8374504
[TBL] [Abstract][Full Text] [Related]
34. Creation of a LIGHT mutant with the capacity to evade the decoy receptor for cancer therapy.
Morishige T; Yoshioka Y; Inakura H; Tanabe A; Yao X; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Biomaterials; 2010 Apr; 31(12):3357-63. PubMed ID: 20117833
[TBL] [Abstract][Full Text] [Related]
35. The lymphotoxin-alpha (LTalpha) subunit is essential for the assembly, but not for the receptor specificity, of the membrane-anchored LTalpha1beta2 heterotrimeric ligand.
Williams-Abbott L; Walter BN; Cheung TC; Goh CR; Porter AG; Ware CF
J Biol Chem; 1997 Aug; 272(31):19451-6. PubMed ID: 9235946
[TBL] [Abstract][Full Text] [Related]
36. Developmental regulation of sensory neurite growth by the tumor necrosis factor superfamily member LIGHT.
Gavaldà N; Gutierrez H; Davies AM
J Neurosci; 2009 Feb; 29(6):1599-607. PubMed ID: 19211867
[TBL] [Abstract][Full Text] [Related]
37. Original Ligand for LTβR Is LIGHT: Insight into Evolution of the LT/LTβR System.
Maeda T; Suetake H; Odaka T; Miyadai T
J Immunol; 2018 Jul; 201(1):202-214. PubMed ID: 29769272
[TBL] [Abstract][Full Text] [Related]
38. TNFSF14 inhibits melanogenesis via NF-kB signaling in melanocytes.
Kim KH; Choi H; Kim HJ; Lee TR
Cytokine; 2018 Oct; 110():126-130. PubMed ID: 29730385
[TBL] [Abstract][Full Text] [Related]
39. Lymphotoxin beta receptor triggering induces activation of the nuclear factor kappaB transcription factor in some cell types.
Mackay F; Majeau GR; Hochman PS; Browning JL
J Biol Chem; 1996 Oct; 271(40):24934-8. PubMed ID: 8798772
[TBL] [Abstract][Full Text] [Related]
40. Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor.
Martín-Vañó S; Miralles-Abella A; Castaño P; Hurtado-Genovés G; Aguilar-Ballester M; Herrero-Cervera A; Vinué A; Martínez-Hervás S; González-Navarro H
Clin Investig Arterioscler; 2023; 35(1):1-11. PubMed ID: 35738949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
